98%
921
2 minutes
20
The P2X receptor is an emerging target for molecular imaging of inflammation in the brain and peripheral tissues. In this work, we focus on five triazole-based ligands with high affinity and selectivity for P2X receptors (, , , , and ), which are amenable to autoradiography and positron emission tomography (PET) imaging. We studied the phenomenon of conformational and rotational changes of these molecules by NMR and calculations. The reaction of ligands and with [F]-fluoride resulted in an isotopic exchange on the pyrimidine ring, leaving the halogen atoms on the acyl moieties intact. The reaction yielded with a radiochemical yield as high as 27% and a molar activity as high as 152 GBq/μmol. Quantitative autoradiography with in sagittal mouse brain cryostat sections indicated a maximum specific binding ( ) of 15.8 ± 2.8 pmol/g of wet weight and a dissociation constant ( ) of 16.6 ± 5.1 nM. Thus, we present the first synthesis of by isotopic exchange and confirm its specific binding at mouse brain P2X receptors, which should warrant its use in animal and human PET investigations.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12368693 | PMC |
http://dx.doi.org/10.1021/acsomega.5c04531 | DOI Listing |
Transl Vis Sci Technol
September 2025
Wilmer Eye Institute, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Purpose: The purinergic receptor P2X4 is critical to transduction of ocular pain. The aim of this study was to investigate the therapeutic potential of the P2X4 receptor antagonist BAY-776 in alleviating chronic ocular pain.
Methods: Chronic ocular pain was induced in male rats (8-9 weeks old; n = 12 per group) via double lacrimal gland removal (DLGR).
Microglia, resident immune sentinels in the brain, are crucial in responding to tissue damage, infection, damage signals like purines (ATP/ ADP), and clearing cellular debris. It is currently unknown how microglial reactivity progresses and contributes to seizure development following Theiler's Murine Encephalomyelitis Virus (TMEV) infection. Previously, our group has demonstrated that purinergic signaling in microglia is disrupted in the hippocampus of TMEV-infected mice.
View Article and Find Full Text PDFACS Omega
August 2025
Institute of Organic Chemistry, Johannes Kepler University Linz, Altenberger Straße 69, 4040 Linz, Austria.
The P2X receptor is an emerging target for molecular imaging of inflammation in the brain and peripheral tissues. In this work, we focus on five triazole-based ligands with high affinity and selectivity for P2X receptors (, , , , and ), which are amenable to autoradiography and positron emission tomography (PET) imaging. We studied the phenomenon of conformational and rotational changes of these molecules by NMR and calculations.
View Article and Find Full Text PDFNeuropharmacology
November 2025
International Translational Neuroscience Research Institute, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China. Electronic address:
We celebrate the life of our colleague Francesco Di Virgilio, who in his very last public lecture discussed purinergic signaling in neuroglia in physiology and pathophysiology. Here, we write on a subset of a unique type of peripheral neuroglia, enteric glia that accompany enteric neurons in the enteric nervous system of the gut and act to maintain homeostasis in enteric neurocircuits. Bi-directional communication between enteric neurons and glia is majorly mediated by purines.
View Article and Find Full Text PDFFuture Med Chem
August 2025
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir, Turkey.
In these review series, recent reports on the design and development of analgesic molecules were reviewed. The primary aim is to examine heterocyclic frameworks involved in pain modulation and, where applicable, to establish structure - activity relationships (SARs). Currently, nine major pathways have been described for pain relief, including prostaglandin synthesis inhibition, opioid receptor modulation, sodium channel blockade, enhancement of serotonin and norepinephrine levels, cannabinoid receptor (CBR) binding, -methyl--aspartate (NMDA) receptor antagonism, transient receptor potential cation channel subfamily V member 1 (TRPV1) antagonism, and P2X purinergic receptor blockade.
View Article and Find Full Text PDF